Bala Venkatesh's Publications

About Bala Venkatesh's Publications

Program Director, Critical Care
  • MBBS,
  • MD (Int.Med),
  • FRCA,
  • FFARCSI,
  • MD (UK),
  • FCICM

  • Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial

    Unknown Date published:

  • Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation

    JAMA Date published:

  • Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation

    JAMA Date published:

  • Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID -19 and severe hypoxaemia-Post hoc exploratory analyses of the COVID STEROID 2 trial

    Acta Anaesthesiologica Scandinavica Date published:

  • Return on Investment Evaluation and Optimal Sizing of Behind-the-Meter Battery Energy Storage Systems in Large Commercial Buildings in Ontario

    2022 IEEE Canadian Conference on Electrical and Computer Engineering (CCECE) Date published:

  • Recruitment characteristics of randomised trials in critical care: A systematic review

    Clinical Trials Date published:

  • Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review

    Clinical Pharmacokinetics Date published:

  • Smart Meter Data Masking Using Conditional Generative Adversarial Networks

    Electric Power Systems Research Date published:

  • Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India

    CHEST Date published:

  • Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia

    Scientific Reports Date published:

  • Redefining critical illness

    Nature Medicine Date published:

  • Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India

    BMJ Open Date published:

  • Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand

    Australian Critical Care Date published:

  • A Comparison of the Commonly Used Surrogate Markers for Citrate Accumulation and Toxicity during Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation

    Blood Purification Date published:

  • Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19

    JAMA Date published:

  • Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

    Intensive Care Medicine Date published: